Skip to main content
Clinical Trials/CTRI/2024/12/078765
CTRI/2024/12/078765Not yet recruitingNot Applicable

A CROSS-SECTIONAL SURVEY STUDY TO OBSERVE THE PREVALENCE OF VARIOUS RACANATMAKA VIKRTI (ANATOMICAL ABNORMALITIES) OF KSÌ£ETRA (FEMALE REPRODUCTIVE ORGANS) CAUSING STRI VANDHYATVA (INFERTILITY)

J S Ayurveda Mahavidyalaya1 site in 1 country50 target enrollmentStarted: January 15, 2025Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
50
Locations
1
Primary Endpoint
with the help of USG - pelvis & adnexa report, The study will derive the prevalence of Racanatmaka vikṛti of kṣetra causing Stri Vandhyatva which may simplify the complexity of the diagnosis of Strī Vandyatva.

Study Overview

Brief Summary

Infertility is the failure to conceive (regardless of cause) after 1 year of unprotected intercourse. Since the Vedic period, Racanatmaka vikrÌ£ti of ksÌ£etra resulting in Vandhyatva (Infertility) has been acknowledged. The first systemic literature of health science Ayurveda has given detailed descriptions in a classified manner. Four important factors as Garbha samÌ£bhava saÌ„magriÌ„ that is rÌ£tu, ksÌ£etra, ambu, and biÌ„ja have been explicated by Ä€caÌ„ryas. These factors are essential for conception. Any irregularity in the Garbha samÌ£bhava saÌ„magriÌ„ can lead to infertility. KsÌ£etra is stated as an important GarbhotpaÌ„daka bhaÌ„va and regarded as one of the most important factors for conception. Different aÌ„caÌ„ryas have different considerations for ksÌ£etra. Some Ä€yurveda scholars considered KsÌ£etra as only garbhāśaya or the whole female body or the female reproductive tract. In this context, we refer to the entire female reproductive system as KsÌ£etra, which includes dÌ£imbagranthi (ovaries), dÌ£imbanalikaÌ„ (fallopian tubes), garbhāśaya (uterus), garbhāśaya bandhana (ligaments of uterus), yoni (vagina).   In any community, infertility affects approximately 5-15% of reproductive-aged couples. Over the past 50 years, its general frequency has been consistent, although the etiology and patient age have changed. There is a corresponding rise in the incidence of infertility as women age. The female is directly responsible in about 40 -55 % of cases. Hence, there is need to observe the prevalence of the congenital and other anatomical abnormalities (racanaÌ„tmaka vikrÌ£ti) that are responsible for Vandhyatva byunderstanding the anatomy of pelvic viscera and the prevalence of various anatomical abnormalities causing female infertility will enable medical professionals to assess patients and treat them appropriately for an effective outcome. The study aims to observe the prevalence of RacanaÌ„tmaka vikrÌ£ti of KsÌ£etra (female reproductive organs) in the development of  *StriÌ„ vandhyatva.*The Objectives of the Study are to do a literary study on the anatomy of female reproductive organs, a literary study of StriÌ„ vandhyatva, and a survey to observe the prevalence of RacanaÌ„tmaka vikrÌ£ti of KsÌ£etra (female reproductive organs) causing StriÌ„ vandhyatva.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
20.00 Year(s) to 40.00 Year(s) (—)
Sex
Female

Inclusion Criteria

  • Patients between 20 to 40 years of age.
  • Women with primary and secondary infertility due to diagnosed anatomical abnormalities in their reproductive organs.
  • Congenital and acquired anomalies related to Female genital organs.
  • (Uterine, tubal, ovarian, cervical, vaginal factors).

Exclusion Criteria

  • Patients below 20 and above 40 years of age.
  • Infertility due to non-anatomical factors: anovulation, uterine dysfunction, cervical cellulitis, vaginitis, and any other systemic illness.
  • Infertility associated with hormonal imbalance: hypothalamic, thyroid disorders, etc.

Outcomes

Primary Outcomes

with the help of USG - pelvis & adnexa report, The study will derive the prevalence of Racanatmaka vikṛti of kṣetra causing Stri Vandhyatva which may simplify the complexity of the diagnosis of Strī Vandyatva.

Time Frame: The observation will be completed within 1 year and 6 months of the duration.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
J S Ayurveda Mahavidyalaya
Sponsor Class
Research institution and hospital
Responsible Party
Principal Investigator
Principal Investigator

Dr Riddhi Ashokbhai Amreliya

J. S. Ayurveda Mahavidyalaya

Study Sites (1)

Loading locations...

Similar Trials